RE:management must by nowPrometic is not a shoe maker business ,they are in drug making business and before the clients bought their stuff they have to get licences from authority.
When they get those licences , we will see what kind of business man they are ,but now the science is the master piece.
We will see if they are better business man than Roche who buy intermune(perfenidone) for 8 billions.Knowing what we know now (mode of action not known from intermune and nether from Roche).
taking a Look at the site blog«INSPIRE» some time to time ,its obvious that the side effects of the 2 drugs on the market is the main problem for the users .Bring them a new drug with no side effects when they begin the treatment and they will be happy to wait for the results, because now they dump the treatment before seeing results.PLI don't need to find a lots of new clients ,the actuals are just waiting for PBI4050 but they don,t even know the drug is on trial.
Anyway , we are not years away but weeks away (maybe days ) with Plasminogen.